Although immunosuppressive therapy with anti-TNF-α and thiopurine in patients with ulcerative colitis has been associated with a two-to-threefold increase in lymphoma incidence, others have reported no such increase (12, 13). The gene discussed is TNF; the disease is ulcerative colitis.